OBJECTIVES: Prostaglandin E2 (PGE2) is a product of cyclooxygenase (COX) and PGE synthase (PGES) and deactivated by 15-hydroxyprostaglandin dehydrogenase (PGDH). Down-regulation of PGDH contributes to PGE2 accumulation in lung and colon cancers but has not been identified in pancreatic cancer. METHODS: Normal human pancreatic and tumor-matched tissues, as well as MiaPaCa-2 and BxPC-3 cell lines, were assessed for COX-2, microsomal PGES-1, PGDH, and snail homolog 1 (SNAI1) and SNAI2 expressions by real-time polymerase chain reaction and Western blotting and PGE2 by enzyme-linked immunosorbent assay. RESULTS: Normal tissues exhibited low COX-2 messenger RNA (mRNA) and protein expressions and high PGDH mRNA and protein expressions and PGE2 levels at 13 pg/mg of protein. In contrast, tumor tissues exhibited high COX-2 mRNA and protein expressions and low PGDH mRNA and protein expressions and PGE2 levels at 32 pg/mg of protein. Tumor tissues exhibited significantly elevated expressions of SNAI2 mRNA and protein but not SNAI1 because SNAI1 and SNAI2 reportedly down-regulate PGDH expression. The COX-2-positive BxPC-3 but not the COX-2-negative MiaPaCa-2 treated with 100-nmol/L PGE2 induced phosphorylated extracellular signal-related kinase that was blocked by the mitogen-activated protein kinase kinase inhibitor U0126, demonstrating the ability of PGE2 to activate ERK. CONCLUSIONS: These results suggest that enhanced PGE2 production proceeds through the expressions of COX-2 and microsomal PGES-1 and down-regulation of PGDH by SNAI2 in pancreatic tumors.
OBJECTIVES:Prostaglandin E2 (PGE2) is a product of cyclooxygenase (COX) and PGE synthase (PGES) and deactivated by 15-hydroxyprostaglandin dehydrogenase (PGDH). Down-regulation of PGDH contributes to PGE2 accumulation in lung and colon cancers but has not been identified in pancreatic cancer. METHODS: Normal humanpancreatic and tumor-matched tissues, as well as MiaPaCa-2 and BxPC-3 cell lines, were assessed for COX-2, microsomal PGES-1, PGDH, and snail homolog 1 (SNAI1) and SNAI2 expressions by real-time polymerase chain reaction and Western blotting and PGE2 by enzyme-linked immunosorbent assay. RESULTS: Normal tissues exhibited low COX-2 messenger RNA (mRNA) and protein expressions and high PGDH mRNA and protein expressions and PGE2 levels at 13 pg/mg of protein. In contrast, tumor tissues exhibited high COX-2 mRNA and protein expressions and low PGDH mRNA and protein expressions and PGE2 levels at 32 pg/mg of protein. Tumor tissues exhibited significantly elevated expressions of SNAI2 mRNA and protein but not SNAI1 because SNAI1 and SNAI2 reportedly down-regulate PGDH expression. The COX-2-positive BxPC-3 but not the COX-2-negative MiaPaCa-2 treated with 100-nmol/L PGE2 induced phosphorylated extracellular signal-related kinase that was blocked by the mitogen-activated protein kinase kinase inhibitor U0126, demonstrating the ability of PGE2 to activate ERK. CONCLUSIONS: These results suggest that enhanced PGE2 production proceeds through the expressions of COX-2 and microsomal PGES-1 and down-regulation of PGDH by SNAI2 in pancreatic tumors.
Authors: Jason R Mann; Michael G Backlund; F Gregory Buchanan; Taki Daikoku; Vijaykumar R Holla; Daniel W Rosenberg; Sudhansu K Dey; Raymond N DuBois Journal: Cancer Res Date: 2006-07-01 Impact factor: 12.701
Authors: Basil F El-Rayes; Mark M Zalupski; Anthony F Shields; Ann Marie Ferris; Ulka Vaishampayan; Lance K Heilbrun; Raghu Venkatramanamoorthy; Volkan Adsay; Philip A Philip Journal: Invest New Drugs Date: 2005-12 Impact factor: 3.850
Authors: Li Yang; Joseph M Amann; Takefumi Kikuchi; Rut Porta; Marta Guix; Adriana Gonzalez; Kyung-Ho Park; Dean Billheimer; Carlos L Arteaga; Hsin-Hsiung Tai; Raymond DuBois; David P Carbone; David H Johnson Journal: Cancer Res Date: 2007-06-15 Impact factor: 12.701
Authors: Hiroyuki Matsubayashi; Jeffrey R Infante; Jordan Winter; Alison P Klein; Richard Schulick; Ralph Hruban; Kala Visvanathan; Michael Goggins Journal: Cancer Biol Ther Date: 2007-07-09 Impact factor: 4.742
Authors: Yeon-Mi Ryu; Seung-Jae Myung; Young Soo Park; Dong-Hoon Yang; Ho June Song; Jin-Yong Jeong; Sun Mi Lee; Miyeoun Song; Do Hoon Kim; Hyo-Jeong Lee; Soo-Kyung Park; Stephen P Fink; Sandy D Markowitz; Kee Wook Jung; Kyung-Jo Kim; Byong Duk Ye; Jeong-Sik Byeon; Hwoon-Yong Jung; Suk-Kyun Yang; Jin-Ho Kim Journal: Cancer Prev Res (Phila) Date: 2013-02-19
Authors: Andrea Schmidt; James Sinnett-Smith; Steven Young; Hui-Hua Chang; O Joe Hines; David W Dawson; Enrique Rozengurt; Guido Eibl Journal: Surgery Date: 2017-02-20 Impact factor: 3.982
Authors: Hung Pham; C Ekaterina Rodriguez; Graham W Donald; Kathleen M Hertzer; Xiaoman S Jung; Hui-Hua Chang; Aune Moro; Howard A Reber; O Joe Hines; Guido Eibl Journal: Biochem Biophys Res Commun Date: 2013-08-21 Impact factor: 3.575